Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

While shares have posted break-even returns so far in 2024, Pfizer stock has cratered by more than 30% over the ...

Dishant Gupta was director of strategy and operations in the Cambridge office of Ipsen where he learned from co-workers that Ipsen was intent on buying Epizyme in early 2022.

Sage Therapeutics Inc.’s stock tumbled 12.8% early Tuesday, after the company said a mid-stage trial of a treatment for mild ...

ANI Pharmaceuticals acquired Alimera Sciences, boosting its rare disease segment with a couple of durable ophthalmology ...

According to Insider Monkey’s data, 21 hedge funds held stakes in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) as of Q2, with a ...

Indian stock markets poised for a positive start on Monday, driven by global gains and strong sector performance. Sensex and ...

Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Tonix Pharma (TNXP – Research Report) on October 11 and set a price ...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where ...

Leerink Partners, Morgan Stanley, Piper Sandler and Cantor are acting as joint bookrunning managers for the offering. LifeSci Capital, Baird, H.C. Wainwright & Co. and Citizens JMP are acting as lead ...

On Friday, CNS Pharmaceuticals Inc (CNSP) stock saw a modest uptick, ending the day at $0.12 which represents no change from the prior close of of $0.12. The stock opened at $0.12 and touched a low of ...